FINWIRES · TerminalLIVE
FINWIRES

Tigermed Consulting Stock Tumbles as Directors Face Regulatory Probe

By

Hangzhou Tigermed Consulting (HKG:3347) said its directors and controlling shareholders, Ye Xiaoping and Cao Xiaochun, are being investigated in China, according to a Tuesday filing with the Hong Kong bourse.

The clinical trial services provider's shares fell nearly 6% in morning trade on Wednesday.

China's Securities Regulatory Commission launched a probe into Ye and Cao for possible violations regarding information disclosure related to changes in the company's shareholding, the filing said.

Tigermed Consulting said the probe will not affect its day-to-day operations.

Related Articles

Asia

South West Pinnacle Exploration Bags New Orders Worth INR227 Million

South West Pinnacle Exploration (NSE:SOUTHWEST, BOM:543986) has secured three work orders worth a total of 226.8 million Indian rupees for exploration, drilling, and related support services, according to a Tuesday filing to the Indian stock exchanges.The company received two letters of award totaling 96.8 million Indian rupees from Odisha Lift Irrigation Corporation for the installation of successful deep borewells for a solar pumping system in Odisha, India.It also got a work order of 130 million rupees from Hindmetal Exploration Services for the exploration, drilling, and support services in the state of Rajasthan.The three projects will be executed in the current financial year.

BOM:543986NSE:SOUTHWEST
Asia

Shenzhen Airport Logs 2.7% Rise in April Passenger Throughput

Shenzhen Airport (SHE:000089) passenger throughput rose 2.7% year over year to 5.5 million in April, according to a Tuesday filing with the Shenzhen bourse.Cargo and mail throughput increased 1.6% to 169,800 tons.Aircraft movements, or takeoffs and landings, rose 2.3% to 36,770.

SHE:000089
Asia

Mani Books Dividend Income From Overseas Units

Mani (TYO:7730) received dividend income of 2.22 billion yen from three consolidated overseas subsidiaries as part of its group cash management strategy, according to a Tuesday filing on the Tokyo Stock Exchange.The dividends came from Mani Medical Hanoi, Mani Hanoi, and Mani Medical India Private Limited, and were received on April 28.The company said it will book the amount as non-operating income in its standalone financial statements for the fiscal year ending August 2026.

TYO:7730